To the best of our knowledge, there are no reports to this date on the role of AXL–GAS6 in NSCLC BM, and the prognostic significance of AXL–GAS6 expression in lung cancer brain metastases remains undefined. The gene discussed is AXL; the disease is non-small cell lung carcinoma.